| ASAR lncRNAs control DNA replication timing through interactions with multiple hnRNP/RNA binding proteins MJ Thayer, MB Heskett, LG Smith, PT Spellman, PA Yates eLife 13, 2024 | | 2024 |
| Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo A Vermehren-Schmaedick, M Peto, W Wagoner, KE Chiotti, E Ramsey, ... Plos one 19 (5), e0302856, 2024 | | 2024 |
| Abstract PO3-16-03: Investigating HER2DX genomic assay concordance within HER2-positive breast cancer F Brasó-Maristany, L Paré, G Villacampa, M Marín-Aguilera, P Spellman, ... Cancer Research 84 (9_Supplement), PO3-16-03-PO3-16-03, 2024 | | 2024 |
| HER2 heterogeneity and treatment response–associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial Z Li, O Metzger Filho, G Viale, P dell’Orto, L Russo, MA Goyette, A Kamat, ... The Journal of Clinical Investigation 134 (7), 2024 | | 2024 |
| Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer M Marín-Aguilera, P Jares, E Sanfeliu, G Villacampa, E Hernández-Lllán, ... ESMO open 9 (3), 102903, 2024 | | 2024 |
| Abstract A061: A novel genetically engineered mouse model of Myc-driven pancreatic cancer recapitulates phenotypic heterogeneity, metastasis, and therapy resistance seen in … IA English, PJ Worth, KA MacPherson, MB Heskett, V Shah, JL Phipps, ... Cancer Research 84 (2_Supplement), A061-A061, 2024 | | 2024 |
| A novel genetically engineered mouse model of Myc-driven pancreatic cancer recapitulates phenotypic heterogeneity, metastasis, and therapy resistance seen in clinical populations IA English, PJ Worth, KA MacPherson, MB Heskett, V Shah, JL Phipps, ... CANCER RESEARCH 84 (2), 2024 | | 2024 |
| Mixed ctDNA dynamics and decreased detection rates in early-stage lung cancer patients during radiation treatment CT Boniface, K Baker, C Deig, C Halsey, T Kelly, R Rahmani, G Tormoen, ... medRxiv, 2024.06. 03.24308298, 2024 | | 2024 |
| Novel recruitment approaches and operational results for a statewide population Cohort for cancer research: The Healthy Oregon Project Z Zhang, A Shafer, K Johnson-Camacho, A Adey, P Anur, KA Brown, ... Journal of Clinical and Translational Science 8 (1), e32, 2024 | | 2024 |
| Multiplex imaging of localized prostate tumors reveals changes in mast cell type composition and spatial organization of AR-positive cells in the tumor microenvironment C Ak, Z Sayar, G Thibault, E Burlingame, J Eng, A Chitsazan, A Adey, ... bioRxiv, 2023.08. 18.553854, 2023 | | 2023 |
| Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon TD O’Brien, AB Potter, CC Driscoll, G Goh, JH Letaw, S McCabe, ... The American Journal of Human Genetics 110 (8), 1249-1265, 2023 | 5 | 2023 |
| An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences B Gurun, W Horton, D Murugan, B Zhu, P Leyshock, S Kumar, KT Byrne, ... BMC genomics 24 (1), 349, 2023 | | 2023 |
| Supervised learning of high-confidence phenotypic subpopulations from single-cell data T Ren, C Chen, AV Danilov, S Liu, X Guan, S Du, X Wu, MH Sherman, ... Nature Machine Intelligence 5 (5), 528-541, 2023 | 5 | 2023 |
| Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation EA Goldman, PT Spellman, A Agarwal Molecular Case Studies 9 (2), a006251, 2023 | 3 | 2023 |
| Author Correction: The evolutionary history of 2,658 cancers (Nature,(2020), 578, 7793,(122-128), 10.1038/s41586-019-1907-7) M Gerstung, C Jolly, I Leshchiner, S Dentro, S Gonzalez, D Rosebrock, ... Nature Research, 2023 | | 2023 |
| Christopher T. Boniface1, 2* and Paul T. Spellman1, 2 CT Boniface, PT Spellman | | 2023 |
| Epigenetic control of chromosome-associated lncRNA genes essential for replication and stability MB Heskett, AE Vouzas, LG Smith, PA Yates, C Boniface, EE Bouhassira, ... Nature communications 13 (1), 6301, 2022 | 6 | 2022 |
| Blood, Toil, and Taxoteres: Biological Determinants of Treatment-Induced ctDNA Dynamics for Interpreting Tumor Response CT Boniface, PT Spellman Pathology & Oncology Research 28, 1610103, 2022 | 1 | 2022 |
| Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies B Roskams-Hieter, HJ Kim, P Anur, JT Wagner, R Callahan, ... NPJ Precision Oncology 6 (1), 28, 2022 | 29 | 2022 |
| Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data D Sun, X Guan, AE Moran, LY Wu, DZ Qian, P Schedin, MS Dai, ... Nature biotechnology 40 (4), 527-538, 2022 | 167 | 2022 |
Joe GrayBiomedical Engineering, Oregon Health and Science University在 ohsu.edu 的电子邮件经过验证
